Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Wang, Tao  [Clear All Filters]
Journal Article
Yuan M-J, Wang T. The new mechanism of Ghrelin/GHSR-1a on autophagy regulation. Peptides. 2020:170264.
Wang T, Zhong D, Qin Z, He S, Gong Y, Li W, Li X. miR-100-3p inhibits the adipogenic differentiation of hMSCs by targeting PIK3R1 via the PI3K/AKT signaling pathway. Aging (Albany NY). 2020;12.
Liu H, Huang S, Wang W, Wang H, Huang W, Zhai Z, Wang D, Fan Y, Sun J, Li D, et al. Migration deficits of the neural crest caused by CXADR triplication in a human Down syndrome stem cell model. Cell Death Dis. 2022;13(12):1018.
Wang T, Yang J, Mao J, Zhu L, Luo X, Cheng C, Zhang L. ITGA5 inhibition in pancreatic stellate cells re-educates the in vitro tumor-stromal crosstalk. Med Oncol. 2022;40(1):39.
Verneris MR, Miller JS, Hsu KC, Wang T, Sees JA, Paczesny S, Rangarajan H, Lee DA, Spellman SR, Lee SJ. Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia. Blood Adv. 2020;4(7):1350-1356.
Kantarjian HM, DeAngelo DJ, Stelljes M, Liedtke M, Stock W, Gökbuget N, O'Brien SM, Jabbour E, Wang T, White JLiang, et al. Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study. Cancer. 2019.
Chen Y, Xu W, Shafiq M, Song D, Wang T, Yuan Z, Xie X, Yu X, Shen Y, Sun B, et al. Injectable nanofiber microspheres modified with metal phenolic networks for effective osteoarthritis treatment. Acta Biomater. 2022.
Xu X, Huang J, Li J, Liu L, Han C, Shen Y, Zhang G, Jiang H, Lin Z, Xiong N, et al. Induced pluripotent stem cells and Parkinson's disease: modelling and treatment. Cell Prolif. 2016.
Liu Z, Wang T, Zhu Y, Zhao H, Zhou Z, Wu Q. Improvements in gut microbiota dysbiosis in aged mice transplanted with adipose-derived stem cells. Stem Cells Dev. 2023.
Fernandez-Viña MA, Wang T, Lee SJ, Haagenson M, Aljurf M, Askar M, Battiwalla M, Baxter-Lowe L-A, Gajewski J, Jakubowski AA, et al. Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood. 2014.
Liu H, Jin M, Ji M, Zhang W, Liu A, Wang T. Hypoxic pretreatment of adipose-derived stem cell exosomes improved cognition by delivery of circ-Epc1 and shifting microglial M1/M2 polarization in an Alzheimer's disease mice model. Aging (Albany NY). 2022;14(undefined).
Zhang F, Luo H, Peng W, Wang L, Wang T, Xie Z, Zhang J, Dong W, Zheng X, Liu G, et al. Hypoxic condition induced H3K27me3 modification of the LncRNA Tmem235 promoter thus supporting apoptosis of BMSCs. Apoptosis. 2022.
Wang X, Shi Z, Lu H-Y, Kim JJ, Bu W, Villalobos JA, Perera DN, Jung SYun, Wang T, Grimm SL, et al. High-throughput profiling of histone post-translational modifications and chromatin modifying proteins by reverse phase protein array. J Proteomics. 2022:104596.
Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Sr HFinel, Boumendil A, Glass B, Castagna L, Dominietto A, et al. Haploidentical versus matched unrelated donor transplants using post-transplant cyclophosphamide for lymphomas. Transplant Cell Ther. 2022.
Niu Y-Y, Ma L-M, Wang T. Haploidentical haematopoietic stem cell transplantation for the treatment of severe aplastic anaemia patients with high-risk factors who lack an HLA-matched sibling donor. Transfus Clin Biol. 2021.
Story CMcIlwaine, Wang T, Bhatt VRaj, Battiwalla M, Badawy SM, Kamoun M, Gragert L, Brown V, Baxter-Lowe LAnn, Marsh SGe, et al. Genetics of HLA peptide presentation, and impact on outcomes in HLA-matched allo-HCT. Transplant Cell Ther. 2021.
Li J, Shang S, Wang T, Fu B, Wang P, Cai G, Chen X, Li Q. Generation of iPSC from peripheral blood mononuclear cells obtained from a patient with TSC2-PKD1 contiguous gene deletion syndrome. Stem Cell Res. 2021;51:102181.
Wang T, Zhou Y, Zhou R, Huang W, Wang J, Li H, Lei M, Tan X, Zhang Y. Generation of induced pluripotent stem cells (iPSCs) from a Chinese infant (XACHi015-A) with type 2 Long QT syndrome carrying the heterozygous mutation c.1814C>T(p.P605L) in KCNH2. Stem Cell Res. 2021;56:102509.
Wang T, Tang W, Zeng Q, Miao S, Pi C, Li Y, Yue W, Yu S. Generation of induced pluripotent stem cell line (FMCPGHi001-A) from a 25-year-old Chinese Han healthy male donor. Stem Cell Res. 2022;60:102735.
Chen D, Wang T, Ye X, Xu X, Xia W, Fu Y. Generation of induced pluripotent stem cell line derived from FNAIT patient with CD36 deficiency mutations. Stem Cell Res. 2022;61:102749.
Chen F, Wang T, Yang Y, Huang Z, Dong Y, Zhang R, Chen J, Zhou Q. Generation of an induced pluripotent stem cell line (SYSUSCi001-A) from a congenital cataract patient carrying heterozygous mutations in BFSP1 and RHO. Stem Cell Res. 2021;59:102644.
Chiu W, Li A, Wang T, Li W, Zhang X. Generation of a MSX1 knockout human embryonic stem cell line using CRISPR/Cas9 technology. Stem Cell Res. 2022;60:102729.
Tan R, Li J, Peng X, Zhu L, Cai L, Wang T, Su Y, Irani K, Hu Q. GAPDH is critical for superior efficacy of female bone marrow-derived mesenchymal stem cells on pulmonary hypertension. Cardiovasc Res. 2013.
Guo Z-P, Wang T, Xu L-P, Zhang X-H, Wang Y, Huang X-J, Chang Y-J. Factors affecting the CD34(+) cell yields from the second donations of healthy donors: The steady-state lymphocyte count is a good predictive factor. Transfus Apher Sci. 2016.
Han Q, Wang S, Chen D, Gan D, Wang T. Exosomes derived from human umbilical cord mesenchymal stem cells reduce tendon injuries via the miR-27b-3p/ARHGAP5/RhoA signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2022;54(2):1-11.

Pages